Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting | NEJM
Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in Sweden - The Lancet